NIBEC (A138610) Stock Overview
A healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A138610 from our risk checks.
A138610 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
NIBEC Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩16,690.00 |
| 52 Week High | ₩54,300.00 |
| 52 Week Low | ₩15,200.00 |
| Beta | 0.54 |
| 1 Month Change | -14.37% |
| 3 Month Change | -34.93% |
| 1 Year Change | -31.60% |
| 3 Year Change | 33.41% |
| 5 Year Change | -64.97% |
| Change since IPO | 30.90% |
Recent News & Updates
Revenues Not Telling The Story For NIBEC Co., Ltd. (KOSDAQ:138610) After Shares Rise 42%
Despite an already strong run, NIBEC Co., Ltd. ( KOSDAQ:138610 ) shares have been powering on, with a gain of 42% in...Here's Why NIBEC (KOSDAQ:138610) Can Manage Its Debt Responsibly
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...NIBEC Co., Ltd.'s (KOSDAQ:138610) Price Is Right But Growth Is Lacking After Shares Rocket 28%
The NIBEC Co., Ltd. ( KOSDAQ:138610 ) share price has done very well over the last month, posting an excellent gain of...Recent updates
Shareholder Returns
| A138610 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -5.7% | 4.5% | -3.6% |
| 1Y | -31.6% | 6.9% | 148.4% |
Return vs Industry: A138610 underperformed the KR Biotechs industry which returned 6.9% over the past year.
Return vs Market: A138610 underperformed the KR Market which returned 148.4% over the past year.
Price Volatility
| A138610 volatility | |
|---|---|
| A138610 Average Weekly Movement | 9.1% |
| Biotechs Industry Average Movement | 11.2% |
| Market Average Movement | 9.3% |
| 10% most volatile stocks in KR Market | 16.5% |
| 10% least volatile stocks in KR Market | 4.9% |
Stable Share Price: A138610 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A138610's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 96 | n/a | nibec.co.kr |
NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is based in Jincheon-eup, South Korea.
NIBEC Co., Ltd. Fundamentals Summary
| A138610 fundamental statistics | |
|---|---|
| Market cap | ₩193.14b |
| Earnings (TTM) | ₩7.30b |
| Revenue (TTM) | ₩32.34b |
Is A138610 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A138610 income statement (TTM) | |
|---|---|
| Revenue | ₩32.34b |
| Cost of Revenue | ₩11.76b |
| Gross Profit | ₩20.59b |
| Other Expenses | ₩13.29b |
| Earnings | ₩7.30b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 641.95 |
| Gross Margin | 63.65% |
| Net Profit Margin | 22.56% |
| Debt/Equity Ratio | 18.8% |
How did A138610 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/06 14:14 |
| End of Day Share Price | 2026/07/06 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
NIBEC Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.